Published in Ophthalmology on February 01, 1999
ω-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol (2012) 2.23
Test-retest reliability of the multifocal electroretinogram and humphrey visual fields in patients with retinitis pigmentosa. Doc Ophthalmol (2004) 1.94
A comparison of visual field sensitivity to photoreceptor thickness in retinitis pigmentosa. Invest Ophthalmol Vis Sci (2010) 1.79
ABCA4 disease progression and a proposed strategy for gene therapy. Hum Mol Genet (2008) 1.69
Probing mechanisms of photoreceptor degeneration in a new mouse model of the common form of autosomal dominant retinitis pigmentosa due to P23H opsin mutations. J Biol Chem (2011) 1.55
Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis pigmentosa. Am J Ophthalmol (2013) 1.34
Relationships among multifocal electroretinogram amplitude, visual field sensitivity, and SD-OCT receptor layer thicknesses in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci (2012) 1.20
Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa. JAMA Ophthalmol (2013) 1.20
Allelic heterogeneity and genetic modifier loci contribute to clinical variation in males with X-linked retinitis pigmentosa due to RPGR mutations. PLoS One (2011) 1.16
A novel GCAP1(N104K) mutation in EF-hand 3 (EF3) linked to autosomal dominant cone dystrophy. Vision Res (2008) 1.12
Vision test variability in retinitis pigmentosa and psychosocial factors. Optom Vis Sci (2011) 1.02
[Hereditary retinochoroidal dystrophies. Part 2: differential diagnosis]. Ophthalmologe (2004) 1.02
Autosomal recessive retinitis pigmentosa caused by mutations in the MAK gene. Invest Ophthalmol Vis Sci (2011) 0.98
Protein misfolding and retinal degeneration. Cold Spring Harb Perspect Biol (2011) 0.96
Phenotypic characterization of a large family with RP10 autosomal-dominant retinitis pigmentosa: an Asp226Asn mutation in the IMPDH1 gene. Am J Ophthalmol (2005) 0.95
Phenotypic characterization of 3 families with autosomal dominant retinitis pigmentosa due to mutations in KLHL7. Arch Ophthalmol (2011) 0.92
Test-Retest Intervisit Variability of Functional and Structural Parameters in X-Linked Retinoschisis. Transl Vis Sci Technol (2014) 0.91
VFMA: Topographic Analysis of Sensitivity Data From Full-Field Static Perimetry. Transl Vis Sci Technol (2015) 0.91
Isolated mesopic rod and cone electroretinograms realized with a four-primary method. Doc Ophthalmol (2011) 0.90
RPGR-associated retinal degeneration in human X-linked RP and a murine model. Invest Ophthalmol Vis Sci (2012) 0.90
[Retinitis pigmentosa - a review. Pathogenesis, guidelines for diagnostics and perspectives]. Ophthalmologe (2012) 0.90
Four-year placebo-controlled trial of docosahexaenoic acid in X-linked retinitis pigmentosa (DHAX trial): a randomized clinical trial. JAMA Ophthalmol (2014) 0.90
Retinal disease course in Usher syndrome 1B due to MYO7A mutations. Invest Ophthalmol Vis Sci (2011) 0.90
The cost-effectiveness of the Argus II retinal prosthesis in Retinitis Pigmentosa patients. BMC Ophthalmol (2014) 0.87
Multimodal Imaging of Central Retinal Disease Progression in a 2-Year Mean Follow-up of Retinitis Pigmentosa. Am J Ophthalmol (2015) 0.87
Repair of rhodopsin mRNA by spliceosome-mediated RNA trans-splicing: a new approach for autosomal dominant retinitis pigmentosa. Mol Ther (2015) 0.85
Distinct signature of altered homeostasis in aging rod photoreceptors: implications for retinal diseases. PLoS One (2010) 0.85
Intervisit variability of visual parameters in Leber congenital amaurosis caused by RPE65 mutations. Invest Ophthalmol Vis Sci (2013) 0.85
A comparison of progressive loss of the ellipsoid zone (EZ) band in autosomal dominant and x-linked retinitis pigmentosa. Invest Ophthalmol Vis Sci (2014) 0.85
Witnessing the first sign of retinitis pigmentosa onset in the allegedly normal eye of a case of unilateral RP: a 30-year follow-up. Doc Ophthalmol (2016) 0.83
Long-term Follow-up of Patients With Retinitis Pigmentosa Receiving Intraocular Ciliary Neurotrophic Factor Implants. Am J Ophthalmol (2016) 0.82
Multi-centre variability of ISCEV standard ERGs in two normal adults. Doc Ophthalmol (2015) 0.81
Disease course of patients with unilateral pigmentary retinopathy. Invest Ophthalmol Vis Sci (2011) 0.81
Principal components' analysis of multifocal electroretinogram in retinitis pigmentosa. Indian J Ophthalmol (2011) 0.81
Polymorphic variation of RPGRIP1L and IQCB1 as modifiers of X-linked retinitis pigmentosa caused by mutations in RPGR. Adv Exp Med Biol (2012) 0.80
Bilateral Concordance of the Fundus Hyperautofluorescent Ring in Typical Retinitis Pigmentosa Patients. Ophthalmic Genet (2013) 0.79
Reliability of a Manual Procedure for Marking the EZ Endpoint Location in Patients with Retinitis Pigmentosa. Transl Vis Sci Technol (2016) 0.75
Variation in rod and cone density from the fovea to the mid-periphery in healthy human retinas using adaptive optics scanning laser ophthalmoscopy. Eye (Lond) (2016) 0.75
Effect of shorter dark adaptation on ISCEV standard DA 0.01 and DA 3 skin ERGs in healthy adults. Doc Ophthalmol (2016) 0.75
Dark-Adapted Chromatic Perimetry for Measuring Rod Visual Fields in Patients with Retinitis Pigmentosa. Transl Vis Sci Technol (2017) 0.75
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther (2011) 4.42
Clinical use of the total artificial heart. N Engl J Med (1984) 2.94
A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. N Engl J Med (1983) 2.85
ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1996) 2.81
The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. N Engl J Med (1984) 2.71
An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO). J Am Coll Cardiol (1996) 2.46
Restricted transport in small pores. A model for steric exclusion and hindered particle motion. Biophys J (1974) 2.42
The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis (1988) 2.42
Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet (1968) 2.29
HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies. Circulation (1991) 2.22
Integration of genetic, clinical, and INR data to refine warfarin dosing. Clin Pharmacol Ther (2010) 2.21
Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project. Am Heart J (1990) 2.14
Mechanism of osmotic flow in porous membranes. Biophys J (1974) 2.07
Oral flecainide acetate for the treatment of ventricular arrhythmias. N Engl J Med (1981) 1.99
Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation (2000) 1.92
Standardized full-field electroretinography. Normal values and their variation with age. Arch Ophthalmol (1992) 1.92
Coronary spasm producing coronary thrombosis and myocardial infarction. N Engl J Med (1983) 1.91
Idiopathic cardiomyopathy, age, and suppressor-cell dysfunction as risk determinants of lymphoma after cardiac transplantation. Lancet (1978) 1.87
Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation (1998) 1.86
Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation (2000) 1.74
Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation (1995) 1.73
Implementation of a computerized cardiovascular information system in a private hospital setting. Am Heart J (1998) 1.68
S-cone function in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci (1993) 1.65
Patient information recall in a rheumatology clinic. Rheumatol Rehabil (1979) 1.62
Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation (2001) 1.61
Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group. Circulation (1991) 1.59
HLA haplotypes in a family with multiple cases of rheumatoid arthritis. J Rheumatol (1982) 1.59
Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol (1996) 1.55
Partitioning and diffusion of proteins and linear polymers in polyacrylamide gels. Biophys J (1996) 1.46
Changes in spontaneous variability of ventricular ectopic activity as a function of time in patients with chronic arrhythmias. Circulation (1988) 1.45
Patient preferences and the bedside manner. Med Educ (1982) 1.41
Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study design. Pharmacogenomics J (2011) 1.38
Nuclear preparations of SV40-transformed cells contain tumor-specific transplantation antigen activity. Virology (1977) 1.37
Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol (1990) 1.35
Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm--paradoxic or predictable? Circulation (1993) 1.28
Reduction in QT interval dispersion by successful thrombolytic therapy in acute myocardial infarction. TEAM-2 Study Investigators. Circulation (1994) 1.26
Malignant neoplasms following cardiac transplantation. JAMA (1978) 1.24
Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. Am J Cardiol (2001) 1.24
Treatment of breast cancer: doctor/patient communication and psychosocial implications. Proc R Soc Med (1975) 1.23
Risk factors for congenital hypothyroidism: an investigation of infant's birth weight, ethnicity, and gender in California, 1990-1998. Teratology (2000) 1.23
Model pores of molecular dimension. The preparation and characterization of track-etched membranes. Biophys J (1972) 1.21
Kinetics and yield of singlet oxygen photosensitized by hypericin in organic and biological media. Photochem Photobiol (1998) 1.21
Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease. J Am Coll Cardiol (2000) 1.20
A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction. Circulation (1984) 1.19
Coffee consumption and cause-specific mortality. Association with age at death and compression of mortality. J Clin Epidemiol (1992) 1.17
Rod ERGs in retinitis pigmentosa and cone-rod degeneration. Invest Ophthalmol Vis Sci (1987) 1.15
Expression and thermal stability of simian virus 40 tumor-specific transplantation antigen and tumor antigen in wild type- and tsA mutant-transformed cells. J Virol (1977) 1.15
Neutrophil dysfunction in diabetes mellitus. J Lab Clin Med (1975) 1.15
SV40 transformation of mouse brain cells: critical role of gene A in maintenance of the transformed phenotype. J Cell Physiol (1976) 1.14
The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: the mechanism of action in the treatment of parkinsonism. Ann Neurol (1985) 1.13
HLA A, B and DR typing in idiopathic dilated cardiomyopathy: a search for immune response factors. Am J Cardiol (1984) 1.13
Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpoints. Ann Hum Genet (2005) 1.13
Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects. Clin Pharmacol Ther (1988) 1.12
Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy. Circulation (2001) 1.12
A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy. Am J Cardiol (1985) 1.08
Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo. Am J Med (1990) 1.08
Hamstrings vs. patella tendon for anterior cruciate ligament reconstruction: a randomised controlled trial. Knee (2001) 1.08
Impact of field-transmitted electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction. Am J Cardiol (1990) 1.07
Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide. J Am Coll Cardiol (1986) 1.07
Treatment of ventricular arrhythmias by United States cardiologists: a survey before the Cardiac Arrhythmia Suppression Trial results were available. Am J Cardiol (1990) 1.06
A comparison of visual function tests in eyes with maculopathy. Ophthalmology (1986) 1.05
Genetic mapping of a novel familial form of infantile hemangioma. Am J Med Genet (1999) 1.05
Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarction. Am Heart J (1992) 1.03
Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group. Am J Cardiol (1996) 1.03
Development of an in vivo model of human multiple myeloma bone disease. Blood (1996) 1.00
Familial automaticity-conduction disorder with associated cardiomyopathy. West J Med (1986) 1.00
Clinically silent atrial septal defects with evidence for cerebral embolization. Ann Intern Med (1986) 0.99
Quantification of aortic regurgitation utilizing continuous wave Doppler ultrasound. J Am Coll Cardiol (1986) 0.99
Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy. Lancet (1982) 0.97
Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold. Am J Cardiol (1983) 0.96
Ruminal and intestinal degradability of distillers grains plus solubles varies by source. J Dairy Sci (2007) 0.96
Cytomegalovirus induction of interleukin-6 in lung fibroblasts occurs independently of active infection and involves a G protein and the transcription factor, NF-kappaB. J Infect Dis (1999) 0.95
The femoral venous approach to endomyocardial biopsy: comparison with internal jugular and transarterial approaches. Am J Cardiol (1984) 0.95
Evaluation of suppressor immune regulatory function in idiopathic congestive cardiomyopathy and rheumatic heart disease. Br Heart J (1981) 0.95
Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study. Circulation (1994) 0.94
Age-related changes in the color-match-area effect. Vision Res (1996) 0.94
Lysophosphatidic acid and EGF stimulate mitogenesis in human airway smooth muscle cells. Am J Physiol (1997) 0.94
HLA-DR typing and lymphocyte subset evaluation in rheumatic heart disease: a search for immune response factors. Am Heart J (1986) 0.94
Predictive value of immunofluorescence and electron microscopic evaluation of endomyocardial biopsies in the diagnosis and prognosis of myocarditis and idiopathic dilated cardiomyopathy. Am Heart J (1987) 0.93
Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. J Am Coll Cardiol (1999) 0.93
Purification and properties of the diheme cytochrome (cytochrome c-552) from Pseudomonas perfectomarinus. FEBS Lett (1981) 0.92
Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group. Am Heart J (1992) 0.92
Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. Circulation (1991) 0.92
Clinical electrophysiologic effects of tocainide. Circulation (1978) 0.91
Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins. J Lipid Res (1997) 0.90
Biologic rhythm disorders, depression, and phototherapy. A new hypothesis. Psychiatr Clin North Am (1987) 0.89
The focal electroretinogram in fellow eyes of patients with idiopathic macular holes. Arch Ophthalmol (1988) 0.88
A model of pulsatile flow in a uniform deformable vessel. J Biomech (1992) 0.88
Development of the False Root-knot Nematode, Nacobbus aberrans, on Sugarbeet. J Nematol (1983) 0.88
High-dose doxorubicin: an exploration of the dose-response curve in human neoplasia. Cancer Treat Rep (1982) 0.88
Nutrition and cancer education: ten years of progress. J Cancer Educ (2000) 0.87
Tumor-specific transplantation antigen is expressed during SV40 lytic infection with wild-type and tsA mutant viruses. Virology (1977) 0.87